Formisano B - Search Results

1

A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer.

Pusceddu S, Bajetta E, Carcangiu ML, Formisano B, Ducceschi M, Buzzoni R. Pusceddu S, et al. Among authors: formisano b. Crit Rev Oncol Hematol. 2012 Feb;81(2):185-95. doi: 10.1016/j.critrevonc.2011.03.008. Epub 2011 Apr 23. Crit Rev Oncol Hematol. 2012. PMID: 21515070 Review.

2

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.

Bajetta E, Stani SC, De Candis D, Zaffaroni N, Zilembo N, Cortinovis D, Aglione S, Mariani L, Formisano B, Bidoli P. Bajetta E, et al. Among authors: formisano b. Ann Oncol. 2003 Feb;14(2):242-7. doi: 10.1093/annonc/mdg060. Ann Oncol. 2003. PMID: 12562651 Free article. Clinical Trial.

3

Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.

Bidoli P, Stani SC, Mariani L, De Candis D, Cortinovis D, Aglione S, Zilembo N, Toffolatti L, Formisano B, Bajetta E. Bidoli P, et al. Among authors: formisano b. Lung Cancer. 2004 Feb;43(2):203-8. doi: 10.1016/j.lungcan.2003.09.003. Lung Cancer. 2004. PMID: 14739041 Clinical Trial.

4

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma.

Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli MR, Queirolo P, Taveggia P, Bernengo MG, Legha SS, Formisano B, Cascinelli N. Bajetta E, et al. Among authors: formisano b. Ann Oncol. 2006 Apr;17(4):571-7. doi: 10.1093/annonc/mdl007. Epub 2006 Feb 9. Ann Oncol. 2006. PMID: 16469753 Free article. Clinical Trial.

5

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Bajetta E, Catena L, Procopio G, De Dosso S, Bichisao E, Ferrari L, Martinetti A, Platania M, Verzoni E, Formisano B, Bajetta R. Bajetta E, et al. Among authors: formisano b. Cancer Chemother Pharmacol. 2007 Apr;59(5):637-42. doi: 10.1007/s00280-006-0306-6. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937105

6

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.

Bidoli P, Zilembo N, Cortinovis D, Mariani L, Isa L, Aitini E, Cullurà D, Pari F, Nova P, Mancin M, Formisano B, Bajetta E. Bidoli P, et al. Among authors: formisano b. Ann Oncol. 2007 Mar;18(3):461-7. doi: 10.1093/annonc/mdl415. Epub 2006 Nov 16. Ann Oncol. 2007. PMID: 17110590 Free article. Clinical Trial.

7

Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes.

Bajetta E, Catena L, Ducceschi M, Pusceddu S, Milione M, Maccauro M, Bajetta R, Procopio G, Buzzoni R, Formisano B, Di Guardo L, Platania M. Bajetta E, et al. Among authors: formisano b. Tumori. 2009 Jul-Aug;95(4):501-7. doi: 10.1177/030089160909500416. Tumori. 2009. PMID: 19856664

8

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report.

Valente M, Catena L, Milione M, Pusceddu S, Formisano B, Bajetta E. Valente M, et al. Among authors: formisano b. Case Rep Oncol. 2010 Jul 2;3(2):202-207. doi: 10.1159/000317313. Case Rep Oncol. 2010. PMID: 20740197 Free PMC article.

9

Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.

Platania M, Agustoni F, Formisano B, Vitali M, Ducceschi M, Pietrantonio F, Zilembo N, Gelsomino F, Pusceddu S, Buzzoni R. Platania M, et al. Among authors: formisano b. Target Oncol. 2011 Sep;6(3):181-6. doi: 10.1007/s11523-011-0185-6. Epub 2011 Jun 11. Target Oncol. 2011. PMID: 21667119

10

Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?

Catena L, Bichisao E, Milione M, Valente M, Platania M, Pusceddu S, Ducceschi M, Zilembo N, Formisano B, Bajetta E. Catena L, et al. Among authors: formisano b. Tumori. 2011 Sep-Oct;97(5):564-7. doi: 10.1177/030089161109700504. Tumori. 2011. PMID: 22158484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page